Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07300540 · ClinicalTrials.gov registry record · NA

Real-World Study of a Calcium Sodium Phosphosilicate Anti-Sensitivity Toothpaste for Dentin Hypersensitivity Relief

A NA study of Dentin Sensitivity, sponsored by HALEON.

Recruiting
Registry status
NA
Development phase
500
Enrollment target
1
Study location

NCT07300540 is a NA study of Dentin Sensitivity that is actively recruiting participants, run by HALEON. The registered enrollment target is 500 participants, above the 110-participant average among 3 other Dentin Sensitivity trials with a reported enrollment target (355% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07300540, a NA study of Dentin Sensitivity, is actively recruiting participants, sponsored by HALEON.

RECRUITING
Registry status
NA
Development phase
500 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to evaluate the impact of a commercially available desensitizing dentifrice containing 5 percent (%) Calcium sodium phosphosilicate (CSPS) on oral health related quality of life (OHrQoL) in a DH (Dentin Hypersensitivity) population in a real-world setting.

Conditions Studied

Interventions

  • OTHER Calcium sodium phosphosilicate (CSPS) Toothpaste

Study Locations (1)

Nevada

  • Citruslabs (Virtual Site) - Las Vegas

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2026-03-04
Est. Completion 2026-11
Phase NA

Sponsor

HALEON

34 total trials

What the Registry Record Tells You About NCT07300540

The ClinicalTrials.gov registry entry for NCT07300540 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 110-participant average among 3 other Dentin Sensitivity trials with a reported enrollment target (355% higher). The listed sponsor is HALEON, which has 34 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dentin Sensitivity appearing as the primary indexed condition, and to 1 intervention - of which Calcium sodium phosphosilicate (CSPS) Toothpaste is the first listed.

NCT07300540 reports 1 study location spanning 1 distinct geographic area - top geographies include Nevada.

Frequently Asked Questions

What is clinical trial NCT07300540 about?

NCT07300540 is a clinical study titled "Real-World Study of a Calcium Sodium Phosphosilicate Anti-Sensitivity Toothpaste for Dentin Hypersensitivity Relief". The aim of this study is to evaluate the impact of a commercially available desensitizing dentifrice containing 5 percent (%) Calcium sodium phosphosilicate (CSPS) on oral health related quality of life (OHrQoL) in a DH (Dentin Hypersensitivity) population in a real-world setting.

What is the current status of trial NCT07300540?

This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2026-03-04. Estimated completion is 2026-11.

What conditions does trial NCT07300540 study?

This clinical trial studies the following conditions: Dentin Sensitivity.

What interventions are being tested in trial NCT07300540?

The interventions under investigation include: Calcium sodium phosphosilicate (CSPS) Toothpaste (OTHER).

Who is sponsoring clinical trial NCT07300540?

This trial is sponsored by HALEON, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07300540 being conducted?

This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dentin Sensitivity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.